Table 1.

Study participants’ characteristics at baseline after the run-in phase.

VariablewTFAiTFArTFA
N = 48N = 31N = 50
Age, years54.5 (50.0–59.8)54.0 (48.0–61.0)55.0 (48.8–58.0)
Gender, % male20 (42)14 (45)21 (42)
Height, m1.7 (1.6–1.8)1.7 (1.6–1.8)1.7 (1.7–1.8)
Weight, kg72.3 (63.4–81.1)71.3 (63.6–83.6)72.4 (61.5–79.7)
BMI, kg/m224.4 (22.5–26.9)25.0 (22.6–28.4)25.0 (22.7–26.4)
Waist circumference, cm89.0 (80.0–96.0)90.0 (83.0–98.0)86.0 (80.0–91.5)
Systolic BP, mmHg119.0 (110.0–129.5)118.0 (108.0–125.0)119.0 (111.5–25.3)
Diastolic BP, mmHg75.5 (70.0–80.0)76.0 (70.0–84.0)78.0 (73.5–80.5)
Insulin, mU/l5.0 (3.5–6.2)4.7 (3.4–6.7)3.9 (2.9–5.6)
Glucose, mmol/l4.9 (4.6–5.2)5.1 (4.7–5.3)4.9 (4.7–5.2)
Vascular function
BAD, baseline, mm4.0 (3.5–4.8)4.2 (3.7–4.9)4.1 (3.7–4.5)
BAD, maximum, mm4.3 (3.7–5.1)4.3 (3.9–5.1)4.2 (3.8–4.7)
Blood velocity, baseline, m/s0.2 (0.2–0.3)0.2 (0.1–0.3)0.2 (0.2–0.3)
Time-to-peak diameter, s46.9 (36.0–56.3)53.0 (35.0–81.6)47.1 (33.0–60.9)
Shear rate, 1/s226.0 (146.3–311.8)196.0 (144.0–273.0)210.0 (147.0–278.0)
Shear rate AUC ttp, 1/s32,360 (24,266–45,750)31,017 (20,810–39,469)29,640 (23,520–47,197)
FMD, %4.3 (3.1–7.2)4.7 (3.7–6.8)5.0 (3.2–7.1)
NMD, %15.5 (12.7–18.1)13.4 (11.4–17.6)14.9 (12.1–17.3)
FMD/NMD ratio0.3 (0.2–0.5)0.3 (0.3–0.5)0.3 (0.2–0.5)
VariablewTFAiTFArTFA
N = 48N = 31N = 50
Age, years54.5 (50.0–59.8)54.0 (48.0–61.0)55.0 (48.8–58.0)
Gender, % male20 (42)14 (45)21 (42)
Height, m1.7 (1.6–1.8)1.7 (1.6–1.8)1.7 (1.7–1.8)
Weight, kg72.3 (63.4–81.1)71.3 (63.6–83.6)72.4 (61.5–79.7)
BMI, kg/m224.4 (22.5–26.9)25.0 (22.6–28.4)25.0 (22.7–26.4)
Waist circumference, cm89.0 (80.0–96.0)90.0 (83.0–98.0)86.0 (80.0–91.5)
Systolic BP, mmHg119.0 (110.0–129.5)118.0 (108.0–125.0)119.0 (111.5–25.3)
Diastolic BP, mmHg75.5 (70.0–80.0)76.0 (70.0–84.0)78.0 (73.5–80.5)
Insulin, mU/l5.0 (3.5–6.2)4.7 (3.4–6.7)3.9 (2.9–5.6)
Glucose, mmol/l4.9 (4.6–5.2)5.1 (4.7–5.3)4.9 (4.7–5.2)
Vascular function
BAD, baseline, mm4.0 (3.5–4.8)4.2 (3.7–4.9)4.1 (3.7–4.5)
BAD, maximum, mm4.3 (3.7–5.1)4.3 (3.9–5.1)4.2 (3.8–4.7)
Blood velocity, baseline, m/s0.2 (0.2–0.3)0.2 (0.1–0.3)0.2 (0.2–0.3)
Time-to-peak diameter, s46.9 (36.0–56.3)53.0 (35.0–81.6)47.1 (33.0–60.9)
Shear rate, 1/s226.0 (146.3–311.8)196.0 (144.0–273.0)210.0 (147.0–278.0)
Shear rate AUC ttp, 1/s32,360 (24,266–45,750)31,017 (20,810–39,469)29,640 (23,520–47,197)
FMD, %4.3 (3.1–7.2)4.7 (3.7–6.8)5.0 (3.2–7.1)
NMD, %15.5 (12.7–18.1)13.4 (11.4–17.6)14.9 (12.1–17.3)
FMD/NMD ratio0.3 (0.2–0.5)0.3 (0.3–0.5)0.3 (0.2–0.5)

Values are median (interquartile range) for continuous variables, and number (%) for count variables.

AUC ttp: area under the curve until peak vasodilation; BAD: brachial artery diameter; BMI: body mass index; BP: blood pressure; FMD: flow-mediated dilation; iTFA: diet enriched with industrial trans fatty acids; NMD: nitroglycerin-mediated dilation; rTFA: diet enriched with ruminant trans fatty acids; wTFA: diet without trans fatty acids

Table 1.

Study participants’ characteristics at baseline after the run-in phase.

VariablewTFAiTFArTFA
N = 48N = 31N = 50
Age, years54.5 (50.0–59.8)54.0 (48.0–61.0)55.0 (48.8–58.0)
Gender, % male20 (42)14 (45)21 (42)
Height, m1.7 (1.6–1.8)1.7 (1.6–1.8)1.7 (1.7–1.8)
Weight, kg72.3 (63.4–81.1)71.3 (63.6–83.6)72.4 (61.5–79.7)
BMI, kg/m224.4 (22.5–26.9)25.0 (22.6–28.4)25.0 (22.7–26.4)
Waist circumference, cm89.0 (80.0–96.0)90.0 (83.0–98.0)86.0 (80.0–91.5)
Systolic BP, mmHg119.0 (110.0–129.5)118.0 (108.0–125.0)119.0 (111.5–25.3)
Diastolic BP, mmHg75.5 (70.0–80.0)76.0 (70.0–84.0)78.0 (73.5–80.5)
Insulin, mU/l5.0 (3.5–6.2)4.7 (3.4–6.7)3.9 (2.9–5.6)
Glucose, mmol/l4.9 (4.6–5.2)5.1 (4.7–5.3)4.9 (4.7–5.2)
Vascular function
BAD, baseline, mm4.0 (3.5–4.8)4.2 (3.7–4.9)4.1 (3.7–4.5)
BAD, maximum, mm4.3 (3.7–5.1)4.3 (3.9–5.1)4.2 (3.8–4.7)
Blood velocity, baseline, m/s0.2 (0.2–0.3)0.2 (0.1–0.3)0.2 (0.2–0.3)
Time-to-peak diameter, s46.9 (36.0–56.3)53.0 (35.0–81.6)47.1 (33.0–60.9)
Shear rate, 1/s226.0 (146.3–311.8)196.0 (144.0–273.0)210.0 (147.0–278.0)
Shear rate AUC ttp, 1/s32,360 (24,266–45,750)31,017 (20,810–39,469)29,640 (23,520–47,197)
FMD, %4.3 (3.1–7.2)4.7 (3.7–6.8)5.0 (3.2–7.1)
NMD, %15.5 (12.7–18.1)13.4 (11.4–17.6)14.9 (12.1–17.3)
FMD/NMD ratio0.3 (0.2–0.5)0.3 (0.3–0.5)0.3 (0.2–0.5)
VariablewTFAiTFArTFA
N = 48N = 31N = 50
Age, years54.5 (50.0–59.8)54.0 (48.0–61.0)55.0 (48.8–58.0)
Gender, % male20 (42)14 (45)21 (42)
Height, m1.7 (1.6–1.8)1.7 (1.6–1.8)1.7 (1.7–1.8)
Weight, kg72.3 (63.4–81.1)71.3 (63.6–83.6)72.4 (61.5–79.7)
BMI, kg/m224.4 (22.5–26.9)25.0 (22.6–28.4)25.0 (22.7–26.4)
Waist circumference, cm89.0 (80.0–96.0)90.0 (83.0–98.0)86.0 (80.0–91.5)
Systolic BP, mmHg119.0 (110.0–129.5)118.0 (108.0–125.0)119.0 (111.5–25.3)
Diastolic BP, mmHg75.5 (70.0–80.0)76.0 (70.0–84.0)78.0 (73.5–80.5)
Insulin, mU/l5.0 (3.5–6.2)4.7 (3.4–6.7)3.9 (2.9–5.6)
Glucose, mmol/l4.9 (4.6–5.2)5.1 (4.7–5.3)4.9 (4.7–5.2)
Vascular function
BAD, baseline, mm4.0 (3.5–4.8)4.2 (3.7–4.9)4.1 (3.7–4.5)
BAD, maximum, mm4.3 (3.7–5.1)4.3 (3.9–5.1)4.2 (3.8–4.7)
Blood velocity, baseline, m/s0.2 (0.2–0.3)0.2 (0.1–0.3)0.2 (0.2–0.3)
Time-to-peak diameter, s46.9 (36.0–56.3)53.0 (35.0–81.6)47.1 (33.0–60.9)
Shear rate, 1/s226.0 (146.3–311.8)196.0 (144.0–273.0)210.0 (147.0–278.0)
Shear rate AUC ttp, 1/s32,360 (24,266–45,750)31,017 (20,810–39,469)29,640 (23,520–47,197)
FMD, %4.3 (3.1–7.2)4.7 (3.7–6.8)5.0 (3.2–7.1)
NMD, %15.5 (12.7–18.1)13.4 (11.4–17.6)14.9 (12.1–17.3)
FMD/NMD ratio0.3 (0.2–0.5)0.3 (0.3–0.5)0.3 (0.2–0.5)

Values are median (interquartile range) for continuous variables, and number (%) for count variables.

AUC ttp: area under the curve until peak vasodilation; BAD: brachial artery diameter; BMI: body mass index; BP: blood pressure; FMD: flow-mediated dilation; iTFA: diet enriched with industrial trans fatty acids; NMD: nitroglycerin-mediated dilation; rTFA: diet enriched with ruminant trans fatty acids; wTFA: diet without trans fatty acids

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close